1. |
Androshchuk V, Patterson T, Redwood SR. Management of coronary artery disease in patients with aortic stenosis. Heart, 2023, 109(4): 322-329.
|
2. |
Del Portillo JH, Farjat-Pasos J, Galhardo A, et al. Aortic stenosis combined with coronary artery disease: SAVR or TAVR - When and how? Can J Cardiol, 2023, 282(23): 1738.
|
3. |
Massussi M, Adamo M, Rosati F, et al. Coronary artery disease and TAVI: Current evidence on a recurrent issue. Catheter Cardiovasc Interv, 2023, 101(6): 1154-1160.
|
4. |
Guo Y, Zhang W, Wu H. Percutaneous versus surgical approach to aortic valve replacement with coronary revascularization: A systematic review andmeta-analysis. Perfusion, 2023: 2676591231178894.
|
5. |
Lérault A, Villecourt A, Decottignies-Dienne T, et al. Catheter versus surgical approach for the management of concomitant aortic stenosis and coronary artery disease: An inverse probability treatment weighting analysis. Arch Cardiovasc Dis, 2023, 116(3): 117-125.
|
6. |
McInerney A, García Márquez M, Tirado-Conte G, et al. In-hospital outcomes following percutaneous versus surgical intervention in the treatment of aortic stenosis and concomitant coronary artery disease. Rev Esp Cardiol (Engl Ed), 2023, 76(8): 600-608.
|
7. |
Tarus A, Tinica G, Bacusca A, et al. Coronary revascularization during treatment of severe aortic stenosis: A meta-analysis of the complete percutaneous approach (PCI plus TAVR) versus the complete surgical approach (CABG plus SAVR). J Card Surg, 2020, 25(8): 2009-2016.
|
8. |
中华医学会心血管病学分会心血管影像学组, 北京医学会心血管病学会影像学组. 中国成人心脏瓣膜病超声心动图规范化检查专家共识. 中国循环杂志, 2021, 36(2): 109-125.
|
9. |
Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol, 2018, 72(18): 2231-2264.
|
10. |
Rao V, Ivanov J, Weisel RD, et al. Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg, 1996, 112(1): 38-51.
|
11. |
Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract, 2012, 120(4): c179-c184.
|
12. |
Hermiller JB, Gunnarsson CL, Ryan MP, et al. The need for future coronary access following surgical or transcatheter aortic valve replacement. Catheter Cardiovasc Interv, 2021, 98(5): 950-956.
|
13. |
Patlolla SH, Schaff HV, Dearani JA, et al. Aortic stenosis and coronary artery disease: Cost of Transcatheter vs surgical management. Ann Thorac Surg, 2022, 114(3): 659-666.
|
14. |
Hamm CW, Beyersdorf F. GARY-The largest registry of aortic stenosis treatment worldwide. Eur Heart J, 2020, 41(6): 733-735.
|
15. |
Pibarot P, Hahn RT, Weissman NJ, et al. Assessment of paravalvular regurgitation following TAVR: A proposal of unifying grading scheme. JACC Cardiovasc Imaging, 2015, 8(3): 340-360.
|
16. |
Barbanti M, Buccheri S, Capodanno D, et al. Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: A comparative analysis from the Italian OBSERVANT study. Int J Cardiol, 2018, 270: 102-106.
|
17. |
Sakurai Y, Yokoyama Y, Fukuhara S, et al. Complete transcatheter versus surgical approach to aortic stenosis with coronary artery disease: A systematic review and meta-analysis. J Thorac Cardiovasc Surg, 2022, 22(2): 1-9.
|
18. |
Faroux L, Chen S, Muntané-Carol G, et al. Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: A systematic review and meta-analysis. Eur Heart J, 2020, 41(29): 2771-2781.
|
19. |
Witberg G, Zusman O, Codner P, et al. Impact of coronary artery revascularization completeness on outcomes of patients with coronary artery disease undergoing transcatheter aortic valve replacement: A meta-analysis of studies using the residual SYNTAX score (Synergy between PCI With taxus and cardiac surgery). Circ Cardiovasc Interv, 2018, 11(3): e006000.
|
20. |
Alperi A, Mohammadi S, Campelo-Parada F, et al. Transcatheter versus surgical aortic valve replacement in patients with complex coronary artery disease. JACC Cardiovasc Interv, 2021, 14(22): 2490-2499.
|
21. |
Elderia A, Gerfer S, Eghbalzadeh K, et al. Surgical versus interventional treatment of concomitant aortic valve stenosis and coronary artery disease. Thorac Cardiovasc Surg, 2023, 71(8): 620-631.
|
22. |
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2021, 143(5): e35-e71.
|
23. |
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J, 2022, 43(7): 561-632.
|
24. |
Baumbach H, Schairer ER, Wachter K, et al. Transcatheter aortic valve replacement- management of patients with significant coronary artery disease undergoing aortic valve interventions: surgical compared to catheter-based approaches in hybrid procedures. BMC Cardiovasc Disord, 2019, 19(1): 108.
|